Premenstrual Syndrome (PMS)

Populations and Risk Factors

Up to 75% of women of childbearing age experience some degree of PMS
Approximately 5% suffer from PMDD (premenstrual dysphoric disorder — psychiatric classification)
Women with pre-existing conditions (asthma, migraines, seizure disorders) may experience worsening during the luteal phase
Those with deficiencies in calcium, magnesium, vitamin B6, and essential fatty acids
Women with high stress levels or history of mood disorders

Hormonal hypersensitivity: Women with PMS may be uniquely hypersensitive to the precipitous drop in estrogen and progesterone before menstruation, even when hormone levels are objectively normal
Neurotransmitter imbalance: Plunging estrogen and progesterone suppress serotonin and opioid peptide activity, strongly related to mood regulation, pain sensitivity, and sleep quality
Nutritional factors: Deficiencies in calcium, magnesium, vitamin B6, and essential fatty acids are frequently implicated in symptom severity
Timing: Symptoms appear 10-14 days before the period and dramatically disappear within the first 4 days after menstruation begins — this timing pattern is diagnostic
PMDD: A more severe form where symptoms are debilitating enough to prevent participation in everyday life. SSRIs are the first-line treatment due to the underlying serotonin deficit

Physical: Bloating, breast tenderness (mastalgia), acne, salt/sugar cravings, headaches, backaches, insomnia, fluid retention
Emotional: Irritability, mood swings, anxiety, depression, confusion, poor concentration
PMDD-specific: Severe exhaustion, anger, loss of control, total lack of desire for relationships
Hyperesthesia (increased sensitivity to touch) during this phase
Reports of clumsiness or impaired productivity
Red flags: Symptoms that do not follow the luteal timing pattern (present throughout the cycle) suggest a different diagnosis — refer for psychiatric or medical evaluation

The defining diagnostic feature is timing: symptoms 10-14 days before menses, disappearing within 4 days of flow
PMDD is the severe form affecting approximately 5% of women, classified as a psychiatric condition
SSRIs are often first-line therapy for severe PMS/PMDD due to the underlying serotonin deficit
Pre-existing conditions (asthma, migraines, seizures) may worsen during the luteal phase
Over 150 symptoms have been documented for PMS

Goal: Palliative support for a predictable cycle of discomfort. Research indicates massage reduces depression and anxiety and alleviates physical symptoms
Safety: PMS is not linked to infection or structural damage. There are no specific contraindications to massage
Hyperesthesia awareness: Some women experience increased sensitivity to touch during this phase — be attentive to verbal and non-verbal cues and adjust pressure accordingly
Environment: For clients with premenstrual migraines or irritability, minimize stimuli (dim lights, avoid heavy scents)
Positioning: Prone for PMS-related backaches. Abdominal work should be gentle and only if requested/tolerated
Breast tenderness: Avoid direct pressure over tender breast tissue. Prone positioning may be uncomfortable during peak tenderness

PMS is defined by its timing: symptoms in the 10-14 days before menses that disappear within 4 days of flow
PMDD is the severe form affecting approximately 5% of women, classified as a psychiatric condition
Massage is safe with no specific contraindications. Benefits include reduced anxiety, depression, and physical discomfort
Be aware of hyperesthesia (increased touch sensitivity) and adjust pressure and environment accordingly
Pre-existing conditions such as asthma, migraines, and seizures may worsen during the luteal phase